A Pharmacokinetic Study in Chinese Healthy Male and Female Volunteers to Investigate the Effect of Food on the Pharmacokinetics of Ensartinib Capsules.
Phase of Trial: Phase I
Latest Information Update: 25 Jul 2019
Price : $35 *
At a glance
- Drugs Ensartinib (Primary)
- Indications CNS cancer; Malignant melanoma; Non-Hodgkin's lymphoma; Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Betta Pharmaceuticals Co Ltd
- 22 Jul 2019 Status changed from recruiting to completed.
- 17 Jul 2018 Planned End Date changed from 1 Apr 2018 to 1 Jul 2018.
- 30 Apr 2018 New trial record